← Back to atlasFullscreen ↗Fullscreen ↗
E593D
Category 4 — Stable Fold, Function DisruptedConflictingTransmembrane · predictedEditorialGlutamate → Aspartate at position 593 · TM9 (589-609), helical transmembrane · WFS1 (Wolframin)
Glu→Asp p593 TM9 AM=0.11 ddg=+0.03 pLDDT=70. ClinVar Conflicting evidence. Atlas mechanism: see structural analysis.
Interactive 3D Structure
Wild-type reference
Wild-type E593 — hydrogen bond to K596
DynaMut2 mutant · E593D
Mutant D593 — polar contact contact to K596 lost
Bond changes · DynaMut2 interaction analysis
1 lost2 gained5 preserved
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | K596 | K596 | Preserved |
| Hydrogen bond | I597 | I597 | Preserved |
| Polar contact | S591 | — | Lost |
| Polar contact | T595 | T595 | Preserved |
| Polar contact | K596 | K596 | Preserved |
| Polar contact | I597 | I597 | Preserved |
| Van der Waals | — | T595 | Gained |
| Van der Waals | — | K596 | Gained |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
DynaMut2 ΔΔG
0.03kcal/mol
Stabilising — mild
AlphaMissense
0.110
LBen
AlphaFold pLDDT
70
model confidence
Schema
Cat 4
Category 4 — Stable Fold, Function Disrupted
Clinical Evidence
ClinVar classificationConflicting classifications of pathogenicity
Review statuscriteria provided, conflicting classifications
Associated conditions(no specific conditions catalogued)
InheritanceConflicting ClinVar classifications.
Population frequency (gnomAD v4)Low frequency · AF 0.011%
cDNA changec.1779G>C
ClinVar accessionVCV000215362
Last evaluated2025/12/29 00:00
Observed in the general population.
Structural Context
Position analysis: LEU592 (2.5 Å — L592V!), LEU594 (2.5 Å), THR595 (4.5 Å — A598T region). Adjacent to L592V in TM9 cluster. The Atlas's neighbor extraction surfaces this variant's contacts.
Amino-acid chemistry
conservative carboxylate swap
Position in the protein
TM9 (589-609)
Druggability Assessment
Cat 4 — see structural prose. AlphaMissense below threshold (AM under-call class) but mechanism is structurally clear from neighbor analysis. Therapeutic strategy: site-directed at the contacts identified above.
Why this matters
TM9 cluster adjacent to L592V/P607L/R/A598T.
Therapeutic Strategy Handoff · prediction
Feed this card to Wolfram Intelligence
Download the E593D PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.
Download E593D PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.
UniProt Domain Annotation
Chain1–890 · Wolframin
Transmembrane589–609 · Helical